Coleman Drake

Coleman Drake

Auto-generated profile, based on publicly available information

Coleman Drake

Department of Health Policy and Management, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2019 in Annals of Internal Medicine
Verified
Journal Article
Closed access
PDF file
CDColeman Drake
Coleman Drake
YZYuehan Zhang
Yuehan Zhang
KCKrisda H. Chaiyachati
Krisda H. Chaiyachati
DPDaniel Polsky
Daniel Polsky

11 July 2021 in Health Services Research
Verified
Journal Article
Closed access
PDF file
CDColeman Drake
Coleman Drake
DNDylan Nagy
Dylan Nagy
TNThuy Nguyen
Thuy Nguyen
KKKevin L. Kraemer
Kevin L. Kraemer
CMChristina Mair
Christina Mair
JDJulie Donohue
Julie Donohue

1 January 2020 in Journal of Addiction Medicine
Verified
Journal Article
Closed access
CDColeman Drake
Coleman Drake
JYJiani Yu
Jiani Yu
NLNicole Lurie
Nicole Lurie
KKKevin Md Kraemer
Kevin Md Kraemer
DPDaniel Polsky
Daniel Polsky
KCKrisda H. Md Chaiyachati
Krisda H. Md Chaiyachati
The COVID-19 pandemic has created an urgent need to expand access to substance use disorder (SUD) treatment through telehealth. A more permanent adoption of tele-SUD treatment options could positively alter the future of SUD treatment. We identify four steps that will help to ensure a broader transition to telehealth will be successful in improving the health outcomes of patients with SUDs. These steps are: (1) investing in telehealth infrastructure to enable health care providers and patients to use telehealth; (2) training and equipping providers to provide SUD treatment through telehealth; (3) providing patients with the financial and social support, hardware, and training necessary to use telehealth; (4) making temporary changes to telehealth law and regulation permanent. We believe these 4 steps will be critical to initiating SUD treatment for many persons that have yet to receive it, and for preserving SUD treatment continuity for millions of other patients both during and after the pandemic.


5 August 2020 in Journal of Substance Abuse Treatment
Verified
Journal Article
Closed access
CDC. Drake
C. Drake
JDJ.M. Donohue
J.M. Donohue
DND. Nagy
D. Nagy
CMC. Mair
C. Mair
KKK.L. Kraemer
K.L. Kraemer
DWD.J. Wallace
D.J. Wallace

3 January 2020 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
CDColeman Drake
Coleman Drake
MJMarian Jarlenski
Marian Jarlenski
YZYuehan Zhang
Yuehan Zhang
DPDaniel Polsky
Daniel Polsky
Access to safe and effective reproductive health services is widely recognized as a public health policy goal.1 The Patient Protection and Affordable Care Act contained several provisions to expand access to reproductive health services. These included expanding insurance coverage to an estimated 20 million people, requiring insurers to cover maternity care, and requiring insurers to cover the full range of US Food and Drug Administration–approved contraceptive methods without patient cost-sharing.2-4 Rigorous empirical work suggests that these provisions have contributed to better access to contraceptive care and may have improved pregnancy-related outcomes.5-8